Krystal Biotech, Inc. (KRYS)
NASDAQ·Healthcare·Biotechnology
$269.62
-1.15%
Mkt Cap $8.07B
Analyst Ratings
Buy
12
Hold
1
Sell
0
Price Target (12 analysts)
$311.00
Range $224.00 – $371.00
Implied Upside
+15.3%
Consensus $311.00 vs current $269.62
NASDAQ·Healthcare·Biotechnology
$269.62
-1.15%
Mkt Cap $8.07B
Buy
12
Hold
1
Sell
0
Price Target (12 analysts)
$311.00
Range $224.00 – $371.00
+15.3%
Consensus $311.00 vs current $269.62